22 april 2017: Lees ook dit artikel:
20 juli 2011: ik ben kanker-actueel aan het herzien en heb gezocht naar vervolgstudies met limonoids, stofjes uit citrusvruchten. Echter kan weinig nieuwe publicaties vinden. 1 abstract uit 2006, een abstract van een laboratorium studie. Klik hier voor dat abstract. Antiproliferative Effects of Citrus Limonoids Against Human Neuroblastoma and Colonic Adenocarcinoma Cells
3 december 2004: Bron Nutraingredients
Bepaalde stofjes - limonoids - alleen voorkomend in citrusvruchten zou neuroblastoomcellen doden en voorkomen dat deze vorm van hersenkanker kan ontstaan. Aldus dierstudies die deze maand gepubliceerd worden. Hier het artikel uit Nutraingredients, daaronder een artikel van het Texas Agricultural University zelf, waar de studie is gedaan, maar zal nog proberen het abstract van de studie op te zoeken.
Orange juice and other citrus contain potent natural compounds – limonoids – which showed dramatic results in killing certain cancer cells. The research was a collaboration between Texas Agricultural Experiment Station scientists Dr. Ed Harris and Dr. Bhumu Patil in Weslaco.
02/12/2004 - Compounds found only in citrus fruits not only fight colon cancer cells but also halt the spread of the childhood cancer neuroblastoma, according to research in laboratory animals.
The researchers based at the Texas Agriculture Experiment Station have already shown that limonoids, of which eight different kinds have so far been characterised from extractions, reduce the ratio of LDL cholesterol to ‘good’ HDL cholesterol, improving the profile for a healthy heart. The new research on neuroblastoma cells, submitted for publication in a scientific journal, adds to the potential benefits of the compound for future use by the food industry.
Neuroblastomas account for about 10 per cent of all cancers in children. Neuroblastoma cells died with relatively small amounts of concentrated limonoids, in 48 hours or less, said the researchers. The citrus findings are important because limonoids induce no side affects, according to the researchers.
Limonoids, a major phytochemical class in citrus fruits, are not the only compounds to offer potential health benefits. A report commissioned by the Australian Citrus Growers Association suggested that the industry could promote the fruits for future mothers - due to their folate content - for blood pressure lowering - for the high potassium and low salt content - and for heart health, owing to the antioxidants, fibre, folate and phytochemicals present.
Dr Bhimu Patil, a plant physiologist at the Texas A&M University-Kingsville Citrus Center, noted that there is some work to go before the food industry can market purified limonoid extracts. “It is very difficult to say whether these could be added to foods as we have not yet done any toxicity testing. However once such studies are completed, we may be able to start producing the isolated compounds in industrial scale with a partner,” he told NutraIngredients.com. He added that isolating the limonoid compounds is challenging "because some are present in very small concentrations".
,br> The researchers are also hoping to learn how limonoids, not present in any other fruits or vegetables, work to fight cancer. Structurally different from the flavonoids also found in citrus fruits, limonoids seem to work against cancer three ways: prevent it from forming, slow the growth of existing cancer and kill cancer cells. Limonoids with a sugar unit attached, limonoid glucosides, are water soluble and tasteless and so could be a suitable food additive. These were also responsible for 'a dramatic effect' on cancer cell death. Patil’s lab is also examining whether the compounds vary among citrus species and at different times of the year.
Hier het originele artikel van de Texas A&M universiteit, maar niet het abstract van de studie: Contact: Kathleen Phillips email@example.com 979-845-2872 Texas A&M University - Agricultural Communications Citrus shows promise for certain childhood cancer ------------------------------------------------------------------------------- Orange juice and other citrus contain potent natural compounds – limonoids – which showed dramatic results in killing certain cancer cells. The research was a collaboration between Texas Agricultural Experiment Station scientists Dr. Ed Harris, shown here in College Station lab, and Dr. Bhumu Patil in Weslaco. (Texas Agricultural Experiment Station photo by Kathleen Phillips) -------------------------------------------------------------------------------- COLLEGE STATION – Orange juice and cancer don't mix. In fact, the popular citrus drink could become a cocktail to prevent or stop the deadly disease in humans. Research by Texas Agriculture Experiment Station scientists has shown that citrus compounds called limonoids targeted and stopped neuroblastoma cells in the lab. They now hope to learn the reasons for the stop-action behavior and eventually try the citrus concoction in humans. Neuroblastomas account for about 10 percent of all cancer in children, Harris said, and is usually a solid tumor in the neck, chest, spinal cord or adrenal gland. The finding in citrus is promising not only for its potential to arrest cancer, but because limonoids induce no side affects, according to Dr. Ed Harris, Experiment Station biochemist who collaborated on the study with Dr. Bhimu Patil, a plant physiologist at the Texas A&M University-Kingsville Citrus Center in Weslaco. "Limonoids are naturally occurring compounds," Harris said. "Unlike other anti-cancer drugs that are toxic, limonoids apparently do not hurt a person. That's the beautiful potential." Patil calls citrus fruit "a vast reservoir of anti-carcinogens." As a plant physiologist, he has succeeded in isolating and purifying a number of limonoids from citrus so that the biochemists could evaluate and compare their anti-cancer abilities at the molecular level. "Limonoids are unique to citrus," Patil said. "They are not present in any other fruits or vegetables. My goal is to find the direct benefits of citrus on human health. " He said a challenging task is to isolate the limonoid compounds, "because some are present in very small concentrations." In fact, citrus breeders seeking to improve the fruit's tastiness for consumers and yield for producers led researchers to discover limonoids – eight of which have been characterized from extractions at the Weslaco facility, according to the researchers. "If I ask why one should drink orange juice every day," Harris noted, "almost everyone would say for vitamin C. That's true, but we also need to learn two new words – flavonoids and limonoids." Harris explained that flavonoids and limonoids – nutrient-packed pigments that give color and taste to fruit – may work against cancer in any of three ways: prevent it from forming, slow the growth of existing cancer, or kill cancer cells. "The limonoids, which differ structurally from flavonoids, seem to do all three," he said of tests in his lab by one of Patil's graduate students, Shibu Poulose, who also worked in Harris' College Station lab. Their work emphasized the compounds' ability to kill existing the neuroblastoma cells with the rationale that if the method and time limonoids take to obliterate the cancer could be found, perhaps scientists could exploit it to help cure the disease. What Poulose found with the extracted limonoid was that the neuroblastoma cells died with relatively small amounts of concentrated limonoids and all in 48 hours or less. They tested this in several ways. First, the limonoids were put through a test to see whether they would quench the oxygen radicals – cancer-causing substances that are destructive to normal cells. The limonoids appeared to be as effective as vitamin C in some of the tests. Test of cell viability were more impressive, however. The neuroblastoma cells were all dead within two days with just 5, 10 and 50 micromoles of limonoids. A micromole is about the equivalent of a tiny skin flake. Some limonoids were more effective than others, but all had killing potential. These amounts of limonoids could easily be obtained from a glass of orange or grapefruit juice. Next, cell viability tests aimed at whether the cell death was caused by apoptosis -- a programmed cell death that spirals in an unstoppable fashion unstoppably once the vulnerable spot on the cell is hit. "Suppose we have cancer and the cancer cell mutates repeatedly until it takes over our organs," he said. "So, a compound comes in and spots those cells with the unusual metabolism and kills them by degrading the cells' protein and fragmenting their DNA until the cells succumb. "Apoptosis is beneficial. It's the immunity system in the body that causes the white cells to recognize things that are not supposed to be there and attack them," Harris explained. Apoptosis early in life removes those white cells that would attack the body's own protein, for example. To test this, the researchers applied 1, 5, 10 and 50 micromolar amounts of limonoids to neuroblastoma cells, then put an apoptosis-blocking chemical on an identical comparison set. Neuroblastoma cells with the blocker did not die, indicating that the limonoids trigger apoptosis which in turn results in the cell death. In their tests, the cancer cells treated with limonoids – but not the apoptosis blocker – all died within 36 hours. The researchers also looked at caspases, destructive enzymes that are activated to cause chain reactions that lead to cell death. "A question was whether limonoids turn on apoptosis which then turn on the caspases and if so, whether that means there is caspases resting in our cells (that could be activated to help fight cancer in us)," he said. This part of the research revealed that with only 5 micromoles of a limonoid known as LG, the cancer cells were dying in as little as 12 hours. "The last phase in killing cancer is to make sure the DNA is destroyed because that is the death knell for the cell," Harris said. "It's intriguing that this amount appeared to have no effect on normal cells and only certain types of cancer cells are vulnerable. Fortunately, breast cancer cells are on the list of vulnerable cells. This makes it all the more imperative to learn how the process works. "We don't have the answer to that yet," he said, "but we have observed that those limonoids with the greatest potency have a closed ring in their chemical structure and that is different from other compounds." Limonoids with a sugar unit attached, the so-called limonoid glucosides, are water soluble and tasteless; those without the sugar, the aglycons, are responsible for bitterness of some citrus. It was the limonoid glucosides, in this study that had "a dramatic effect" on cancer cell death. "Now that we have seen the cancer cells die and in such a short time," Harris said, "we need to find out why they are so vulnerable and exploit it. It could be that ultimately we are able to give patients an oral cocktail of limonoids in such concentration as to stop their cancer." Patil said the researchers also will be studying limonoids to find the limits for adding to food. One of the limonoids, glucoside, is tasteless, he noted, so it might become a food additive for its health benefits, but food engineers would need to know how much to add for human consumption. His lab also is examining whether the compounds vary among citrus species and at different times of the year.
- Alfacalcidol, een vorm van vitamine D geeft bij hersentumoren, 10 Glioblastomen en 1 Astrocytoom een opmerkelijk positief resultaat naast traditionele aanpak van bestraling
- Neuroblastomen: Bepaald stofjes - limonoids - alleen voorkomend in citrusvruchten zou neuroblastoomcellen doden en voorkomen dat deze vorm van hersenkanker - neuroblastoom - kan ontstaan.
- Cyclopamine, een plantenextract, blijkt in een studie met muizen de groei van hersentumoren te blokkeren. Nieuwe in vitro studies met menselijke kankercellen bevest
- Een specifiek eiwit of molecuul - genaamd DSA - van Jimson Weed (Nachtschade) stopt groei kwaadaardige hersentumoren - maligne glioma - in laboratoriumproeven.
- Kytogeen dieet naast chemo en bestraling bij hersentumoren wordt in fase II studie onderzocht in Erasmus medisch centrum
- Melatonine bij hersenmetastasen van solide tumoren en bij vergevorderde borstkanker blijkt therapeutisch effect te geven. copy 1
- Synthetisch gemaakt schorpioenengif - TM-106 geeft opmerkelijk goede resultaten bij mensen met een hersentumor - specifiek bij glioma's.
- Synthetische anti-oxidantenmix - Ebelen geheten maar weinig meer dan een synthetische variant van selenium - beschermt tegen beschadiging van hersencellen veroorzaakt door alcoholgebruik.
- TSC - trans sodium crocetinate: toevoeging van zuurstof aan zuurstof arm weefsel - hypoxia gedurende chemo en bestraling vergroot significant levensduur in dierstudies. Fase II studie is nu open voor patienten met hersentumoren
- Voeding en voedingsuppletie en niet toxische middelen als therapeutische aanvulling bij behandelingen van hersentumoren: een overzicht van recente ontwikkelingen en studies.